Skip to main content
. Author manuscript; available in PMC: 2016 Mar 27.
Published in final edited form as: AIDS. 2015 Mar 27;29(6):683–693. doi: 10.1097/QAD.0000000000000598

Table 2.

Frequencies of subjects by CD4 count at time of initiation of virologic suppressing cART and at start of suppression period

CD4 count (cells/μL) at start of suppressing ART*
CD4 count (cells/μL) at start of virologic suppression** Total
(N=933)		 <200
(N=92)		 200 to 349
(N=118)		 350 to 499
(N=138)		 ≥500
(N=585)
 <200 29 (3%) 24 (26%) 3 (3%) 1 (1%) 1 (0%)
 200 to 349 58 (6%) 20 (22%) 23 (19%) 11 (8%) 4 (1%)
 350 to 499 119 (13%) 19 (21%) 45 (38%) 30 (22%) 25 (4%)
 ≥500 727 (78%) 29 (32%) 47 (40%) 96 (70%) 555 (95%)
*

CD4 reading nearest to start of suppressing ART (up to 6 months prior to ART start date allowed).

**

Nearest CD4 reading to the start of virologic suppression (readings up to 3 months after start allowed).